Glenmark Pharma’s consolidated net profit grew by 181
percent year-on-year to Rs 157 crore in the July-September quarter of financial
year 2012-13.
Consolidated net sales rose by 19 percent to Rs 1,255 crore
from Rs 1,056 crore during the same period.
Analysts on an average had expected net profit of Rs 144
crore on net sales of Rs 1,131 crore for the quarter.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment